Resultados de la búsqueda 231-240 of 1764 for Off-label

  1. Nutrición y comida saludable - Mayo Clinic

    Mayo Clinic Minute: New rule for 'healthy' food labels Jan. 20, 2025, 03 ... Fight off the flu with immune-boosting nutrients Dec. 14, 2023, 02:30 p.m. ...

  2. Oncología (médica) - Ensayos clínicos

    The present study is an open-label, randomized, controlled, two-arm multi-center study of the efficacy of L19TNF treatment in combination with doxorubicin ...

  3. Oncología (médica) - Ensayos clínicos

    The present study is an open-label, randomized, controlled, two-arm multi-center study of the efficacy of L19TNF treatment in combination with doxorubicin ...

  4. Programa de cáncer de pulmón - Ensayos clínicos

    This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with ...

  5. Oncología (médica) - Ensayos clínicos

    This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of AZD0486 monotherapy in adult participants with ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The present study is an open-label, randomized, controlled, two-arm multi-center study of the efficacy of L19TNF treatment in combination with doxorubicin ...

  7. Hematología - Ensayos clínicos

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...

  8. Hematología - Ensayos clínicos

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...

  9. Oncología (médica) - Ensayos clínicos

    This open-label, exploratory study is designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or combinations ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This open-label, exploratory study is designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or combinations ...